CMF
IDXX icon

Counterpoint Mutual Funds’s Idexx Laboratories IDXX Stock Holding History

Counterpoint Mutual Funds’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-506
Closed -$323K – 423
2025
Q3 		$323K Buy
+506
New +$307K 0.03% 285

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JSC
J. Stern & Co London, United Kingdom $1.03B AUM 20.71% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Counterpoint Mutual Funds's IDXX Position: Q4 2025 in Review

Counterpoint Mutual Funds sold out of Idexx Laboratories (IDXX) in Q4 2025, closing a stake of 506 shares — an estimated $323K sold.

Counterpoint Mutual Funds first reported a position in IDXX in Q3 2025 and held it in 1 quarter. The position peaked at $323K in Q3 2025. 1,386 funds tracked by Wall St. Rank hold IDXX as of Q4 2025.

  • Counterpoint Mutual Funds reported no remaining Idexx Laboratories position as of Q4 2025 after selling out during the quarter.
  • Counterpoint Mutual Funds sold 506 Idexx Laboratories shares in Q4 2025, an estimated $323K.
  • Counterpoint Mutual Funds first reported a position in Idexx Laboratories in Q3 2025 and held it in 1 quarter.
  • Counterpoint Mutual Funds's Idexx Laboratories position peaked at $323K in Q3 2025.
  • 1,386 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2025.

Based on Counterpoint Mutual Funds's 13F filing for Q4 2025, filed 12 Feb 2026.